Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-187189
Filing Date
2026-04-28
Accepted
2026-04-28 16:23:09
Documents
11

Document Format Files

Seq Description Document Type Size
1 DEFA14A whwk-20260428.htm   iXBRL DEFA14A 22779
2 GRAPHIC img96983719_0.jpg GRAPHIC 851334
3 GRAPHIC img96983719_1.jpg GRAPHIC 557039
  Complete submission text file 0001193125-26-187189.txt   3247528

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT whwk-20260428.xsd EX-101.SCH 7423
14 EXTRACTED XBRL INSTANCE DOCUMENT whwk-20260428_htm.xml XML 1305
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38560 | Film No.: 26908228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)